This mechanism is further supported by prior evidence linking AIP to obesity-related biomarkers: serum adipocyte-fatty acid binding protein (FABP) and asymmetric dimethylarginine (ADMA) are strongly positively correlated with the AIP (17). Here, GOT2 is linked to obesity disorder.